The Wegovy pill is a tablet containing semaglutide, a substance that mimics the naturally occurring hormone GLP-1 in the body. This hormone plays a role in regulating appetite and satiety and is used in medications targeting weight management. The tablet is being studied as a treatment for adults with obesity or for individuals who are overweight and have at least one weight-related health condition, such as high blood pressure or elevated cholesterol. Initial results are promising but not yet conclusive for all target groups. In addition to the pill, there is also an injectable version of Wegovy for weight loss. The pill has not yet been approved in the European Union and remains in the clinical research phase. We will keep you informed as more information becomes available.
Slimming
Wegovy pill
Tablet

In short
- For the treatment of overweight or obesity
- Not yet approved or available
- Tablet containing semaglutide
- Potential average weight loss of up to 14% in clinical studies
- Side effects appear similar to those of other GLP-1 medications
What is the Wegovy pill?
How does the Wegovy pill work?
Side effects of the Wegovy pill
Research on the Wegovy pill
Status and availability of the Wegovy pill
What treatments are currently available?
Scientific sources
Related products
View other options that may suit you.










